Improved Growth Outlook and Better-Than-Expected Results Boosted Tandem Diabetes Care (TNDM) in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same...
Outlook
How Recent Product Correction and Legal Inquiry May Impact Tandem Diabetes Care’s (TNDM) Investment Outlook
Earlier this month, Tandem Diabetes Care issued a voluntary medical device correction addressing a potential risk that certain t:slim X2...
